Top stories in cardiology: FDA approved left ventricular assist device for advanced heart failure; multivitamins, minerals do not improve cardiovascular outcomes
Click Here to Manage Email Alerts
Among the top stories in cardiology is the FDA approval of a left ventricular assist device for the treatment of patients with advanced heart failure. Multivitamins and minerals did not improve cardiovascular outcomes for patients. Other top stories include triglycerides in low-density lipoproteins predicted cardiovascular events, patients who received care in community health centers that utilized electronic health record tools had improved medication reconciliation and worsened blood pressure, and black patients who survived in-hospital cardiac arrest were less likely to survive long-term compared with white patients.
FDA approves less-invasive LVAD for advanced HF
Medtronic announced that a left ventricular assist device for the treatment of patients with advanced heart failure has received approval from the FDA. Read More.
Multivitamins, minerals fail to improve CV outcomes
Patients who took multivitamins and minerals did not have improved cardiovascular outcomes, according to a review and meta-analysis published in Circulation: Cardiovascular Quality and Outcomes. Read More.
LDL triglycerides predict CVD events
Triglycerides in LDL predicted CVD events and were associated with a genetic variant, according to new findings. Read More.
EHR tools confer improved medication reconciliation but worse BP
Patients who received care in community health centers that utilized electronic health record tools had improved medication reconciliation and worsened blood pressure compared with those who received usual care, according to a study published in JAMA Internal Medicine. Read More.
Long-term survival after in-hospital cardiac arrest varies by race
Black patients who survived in-hospital cardiac arrest were less likely to survive long-term compared with white patients, and about half of the difference was not explained by patient treatments or factors after the event, according to a study published in Circulation. Read More.